Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$25.07
-1.22%
Mkt Cap $405.33M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (17 analysts)
$72.00
Range $65.00 – $81.00
Implied Upside
+187.2%
Consensus $72.00 vs current $25.07
NASDAQ·Healthcare·Biotechnology
$25.07
-1.22%
Mkt Cap $405.33M
Buy
5
Hold
0
Sell
0
Price Target (17 analysts)
$72.00
Range $65.00 – $81.00
+187.2%
Consensus $72.00 vs current $25.07